VAERS reports by lot

GSK Flu lot 23L7C: VAERS reports

36 VAERS reports list lot 23L7C as a GSK Flu vaccine, received between 2016-09-13 and 2020-10-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
42%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3928%
Allergic / Anaphylactic1511%
General / Systemic (non-local)1511%
Musculoskeletal1410%
Dermatological (non-injection-site)1410%
Respiratory139%
Neurological129%
Cardiac / Cardiovascular118%
Psychiatric / Neuropsychiatric32%
Gastrointestinal21%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey12
New York5
Pennsylvania4
Maryland2
Georgia2
California2
Texas1
Hawaii1
Louisiana1
Indiana1
New Mexico1
Connecticut1

Reports by month received

2016-097
2016-1017
2016-115
2017-012
2017-022
2017-062
2020-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.